NewEdge Advisors LLC Sells 10,106 Shares of Agilent Technologies, Inc. $A

NewEdge Advisors LLC cut its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 36.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,951 shares of the medical research company’s stock after selling 10,106 shares during the quarter. NewEdge Advisors LLC’s holdings in Agilent Technologies were worth $2,046,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. State Street Corp increased its stake in shares of Agilent Technologies by 1.9% in the fourth quarter. State Street Corp now owns 12,681,792 shares of the medical research company’s stock worth $1,725,611,000 after purchasing an additional 241,029 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company’s stock valued at $1,006,519,000 after buying an additional 25,139 shares in the last quarter. Morgan Stanley lifted its stake in shares of Agilent Technologies by 15.9% during the 4th quarter. Morgan Stanley now owns 5,041,881 shares of the medical research company’s stock valued at $686,049,000 after buying an additional 692,202 shares in the last quarter. Norges Bank bought a new position in Agilent Technologies in the 4th quarter worth approximately $549,158,000. Finally, Cantillon Capital Management LLC grew its stake in Agilent Technologies by 0.8% in the 4th quarter. Cantillon Capital Management LLC now owns 3,115,638 shares of the medical research company’s stock valued at $423,945,000 after buying an additional 23,493 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on A shares. Barclays boosted their target price on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Robert W. Baird lifted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Royal Bank Of Canada initiated coverage on Agilent Technologies in a research note on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective on the stock. Finally, Jefferies Financial Group assumed coverage on Agilent Technologies in a report on Thursday, July 9th. They set a “hold” rating and a $135.00 price objective on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Price Performance

A stock opened at $148.55 on Friday. The firm has a market cap of $41.95 billion, a P/E ratio of 29.83, a P/E/G ratio of 2.64 and a beta of 1.25. The firm’s fifty day moving average is $135.38 and its 200 day moving average is $125.56. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period in the previous year, the firm posted $1.31 earnings per share. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Research analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were issued a $0.255 dividend. The ex-dividend date was Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s payout ratio is currently 20.48%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.